Sensus Healthcare (SRTS) Fundamental Analysis: Revenue, Earnings & Valuation

0.95 / 10

Underperform

Fundamental assessment rates the stock as Underperform, with a 0.9/10 score indicating weak conditions. Profit‑MV and Net profit/Total profit are relatively strong, but Revenue‑MV, Cash‑MV, ROA and EBIT ratios are negative, suggesting limited financial robustness.

Analysis Checks(3/10)

Revenue-MV

Value-1.05

Score0/3

Weight51.93%

1M Return-4.18%

ROA (%)

Value-13.40

Score1/3

Weight10.82%

1M Return-0.82%

Net cash flow from operating activities / Operating revenue (%)

Value1.92

Score1/3

Weight17.07%

1M Return-1.35%

Profit-MV

Value0.66

Score2/3

Weight-49.04%

1M Return3.09%

Annualized net profit margin on total assets (%)

Value-13.40

Score1/3

Weight10.82%

1M Return-0.82%

EBIT / Total operating revenue (%)

Value-37.50

Score2/3

Weight-1.47%

1M Return0.10%

Asset-MV

Value-0.55

Score1/3

Weight-5.24%

1M Return0.38%

Net profit / Total operating revenue (%)

Value-28.09

Score1/3

Weight11.02%

1M Return-0.84%

Cash-MV

Value0.02

Score1/3

Weight46.49%

1M Return-4.16%

Net profit / Total profit (%)

Value80.21

Score2/3

Weight7.60%

1M Return-0.54%

Is SRTS fundamentally strong?

SRTS scores 0.95/10 on fundamentals and holds a Premium valuation at present. Backed by its -14.85% ROE, -28.09% net margin, -8.49 P/E ratio, 1.36 P/B ratio, and -214.63% earnings growth, these metrics solidify its Underperform investment rating.